NCT05024045 2026-03-03Study of Oral LOXO-338 in Patients With Advanced Blood CancersEli Lilly and CompanyPhase 1 Active not recruiting316 enrolled
NCT07379125 2026-01-30Therapeutic RSK1 Targeting in MyelofibrosisWashington University School of MedicinePhase 1 Not yet recruiting18 enrolled